BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6310870)

  • 1. Multiplicity-dependent induction of viral capsid antigen in Raji cells superinfected with Epstein-Barr virus.
    Fujiwara S; Takada K; Yano S; Osato T
    Virology; 1983 Jul; 128(2):490-4. PubMed ID: 6310870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on the synthesis of Epstein-Barr virus-related antigens induced by superinfection].
    Fujiwara S
    Hokkaido Igaku Zasshi; 1984 Sep; 59(5):586-602. PubMed ID: 6096242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of rabbit antibodies against the viral capsid antigen (VCA) of the Epstein-Barr virus (EBV).
    Vestergaard BF; Hesse J; Norrild B; Klein G
    Int J Cancer; 1978 Mar; 21(3):323-8. PubMed ID: 75856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Productive Epstein-Barr viral infection of the human lymphoblastoid cell line 6410 with release of early antigen inducing and transforming virus.
    Traul KA; Stephens R; Gerber P; Peterson WD
    Int J Cancer; 1977 Aug; 20(2):247-55. PubMed ID: 197026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells.
    Lin JC; Raab-Traub N
    J Virol; 1987 Jun; 61(6):1985-91. PubMed ID: 3033325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
    Fresen KO; zur Hausen H
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative and quantitative analyses of Epstein-Barr virus early antigen diffuse component by western blotting enzyme-linked immunosorbent assay with a monoclonal antibody.
    Lin JC; Choi EI; Pagano JS
    J Virol; 1985 Mar; 53(3):793-9. PubMed ID: 2983091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic cell hybrids between human lymphoma lines. II. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle.
    Klein G; Clements G; Zeuthen J; Westman A
    Int J Cancer; 1976 Jun; 17(6):715-24. PubMed ID: 59708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of adenine arabinoside on Epstein-Barr virus in vitro.
    Coker-Vann M; Dolin R
    J Infect Dis; 1977 Mar; 135(3):447-53. PubMed ID: 191542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-induced proteins. IV. Characterization of an EBV-associated phosphopolypeptide.
    Mueller-Lantzsch N; Yamamoto N
    J Gen Virol; 1981 Aug; 55(Pt 2):333-41. PubMed ID: 6270267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential inhibition of Epstein-Barr virus induction by the amino acid analogue, L-canavanine.
    Yamamoto N; Mueller-Lantzsch N; zur Hausen H
    Int J Cancer; 1980 Apr; 25(4):439-43. PubMed ID: 6246007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns.
    Klein G; Zeuthen J; Ber R; Ernberg I
    J Natl Cancer Inst; 1982 Feb; 68(2):197-202. PubMed ID: 6278188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus (P3HR-1) defective DNA codes for components of both the early antigen and viral capsid antigen complexes.
    Cho MS; Gissmann L; Hayward SD
    Virology; 1984 Aug; 137(1):9-19. PubMed ID: 6089423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-evaluation of a transforming strain of Epstein-Barr virus from the Burkitt lymphoma cell line, Jijoye.
    Sairenji T; Hinuma Y
    Int J Cancer; 1980 Sep; 26(3):337-42. PubMed ID: 6270005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery of transforming EBV from non-producer cells after superinfection with non-transforming P3HR-1 EBV.
    Fresen KO; Cho MS; zur Hausen H
    Int J Cancer; 1978 Oct; 22(4):378-83. PubMed ID: 212377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appearance of early and late components of Epstein-Barr virus-associated membrane antigen in Daudi cells superinfected with P3HR-1 virus.
    Sairenji T; Hinuma Y; Sekizawa T; Yoshida M
    J Gen Virol; 1978 Jan; 38(1):111-20. PubMed ID: 202665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of infection with Epstein-Barr virus. I. Viral DNA replication and formation of noninfectious virus particles in superinfected Raji cells.
    Yajima Y; Nonoyama M
    J Virol; 1976 Jul; 19(1):187-94. PubMed ID: 181594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Suppressive effect of CDDP on induction of the Epstein-Barr virus antigen synthesis by n-butyrate].
    Furukawa M; Kato C; Kamide M; Umeda R
    Nihon Jibiinkoka Gakkai Kaiho; 1989 Feb; 92(2):189-93. PubMed ID: 2545850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential induction of Epstein-Barr virus-related antigens in heterokaryon cultures.
    Yamamoto K; Osato T
    Int J Cancer; 1977 Jun; 19(6):767-74. PubMed ID: 194844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-induced membrane antigens: immunochemical characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells.
    Qualtiere LF; Pearson GR
    Int J Cancer; 1979 Jun; 23(6):808-17. PubMed ID: 89099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.